SEC Form 4 · accession 0001225208-15-020758
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Officer — President, Pharma Pckg Systems
Period of report
Nov 10, 2015
Accepted (ET)
Nov 12, 2015 · 12:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2015 | M | 9,458 | $21.34 | A | 34,068 | D | |
| Common Stock | Nov 10, 2015 | M | 8,562 | $20.425 | A | 42,630 | D | |
| Common StockF1 | Nov 10, 2015 | S | 18,020 | $63.0257 | D | 24,610 | D | |
| Common Stock | holding | — | — | — | 312 | I | By Savings Plan | |
| Common Stock | holding | — | — | — | 1,070 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $20.425 | Nov 10, 2015 | M | 8,562 | D | Feb 22, 2012 | Feb 22, 2021 | Common Stock | 8,562 | 0 | D |
| Stock Option (Right to Buy) | $21.34 | Nov 10, 2015 | M | 9,458 | D | Mar 22, 2011 | Mar 22, 2020 | Common Stock | 9,458 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $63.01 to $63.155, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.